Literature DB >> 3920231

Endocrine, renal, and hemodynamic responses to graded dopamine infusions in normal men.

P D Levinson, D S Goldstein, P J Munson, J R Gill, H R Keiser.   

Abstract

The present study was performed to determine the hemodynamic, hormonal, and natriuretic responses to infusions of dopamine (DA) that reflect physiological as well as pharmacological levels in blood or tissue. In six normal men, DA was infused for 2 h at three fixed dosages (0.03 or 0.1, 0.3, and 3.0 micrograms/kg X min) on three separate occasions, which resulted in increases in mean plasma DA concentrations from basal levels of less than 0.03 ng/ml to 0.69 +/- 0.12, 3.73 +/- 0.40, and 38.4 +/- 3.80 (+/- SE) ng/ml. Mean plasma PRL decreased and DA excretion increased significantly from basal levels during all three DA infusions. Plasma LH decreased and norepinephrine (NE) excretion increased during both the middle and high dose infusions, while sodium excretion, plasma NE, and heart rate increased only during the high dose DA infusion. Basal plasma aldosterone values were low and did not change with DA treatment. PRA, TSH, and FSH also did not change. GH responses were difficult to assess because of the frequency of episodic secretions. Since DA concentrations in hypophysial-portal blood may equal or exceed 1 ng/ml, these results support a role for DA in the acute regulation of PRL, and possibly LH, in normal men. As a natriuretic response occurred only at supraphysiological concentrations of circulating DA, if DA has a physiological role in modulating sodium excretion during normal sodium intake, it must be released from dopaminergic neurons or otherwise locally produced in very high concentrations in the kidney.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3920231     DOI: 10.1210/jcem-60-5-821

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Pattern of plasma levels of catecholamines in familial dysautonomia.

Authors:  F B Axelrod; D S Goldstein; C Holmes; D Berlin; I J Kopin
Journal:  Clin Auton Res       Date:  1996-08       Impact factor: 4.435

2.  Neuronal source of plasma dopamine.

Authors:  David S Goldstein; Courtney Holmes
Journal:  Clin Chem       Date:  2008-09-18       Impact factor: 8.327

3.  The effects of intravenous L-dopa on plasma renin activity, renal function, and blood pressure in man.

Authors:  D Worth; J Harvey; J Brown; M Lee
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 4.  Effects of catecholamines on secretion of adrenocorticotrophic hormone (ACTH) in man.

Authors:  S Al-Damluji; L H Rees
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

5.  Catecholamines 101.

Authors:  David S Goldstein
Journal:  Clin Auton Res       Date:  2010-07-11       Impact factor: 4.435

6.  Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells.

Authors:  B Meister; J Fryckstedt; M Schalling; R Cortés; T Hökfelt; A Aperia; H C Hemmings; A C Nairn; M Ehrlich; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

7.  Metoclopramide, domperidone and dopamine in man: actions and interactions.

Authors:  T M MacDonald
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

8.  Effect of low-dose dopamine infusion on urinary prostaglandin E2 excretion in sick, preterm infants.

Authors:  I Seri; J Hajdu; J Kiszel; T Tulassay; A Aperia
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

9.  Renal effects of atrial natriuretic peptide during dopa-decarboxylase inhibition in patients with essential hypertension.

Authors:  C Fronzaroli; G La Villa; G Strazzulla; M Mannelli; F Franchi
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  An increase in renal dopamine does not stimulate natriuresis after fava bean ingestion.

Authors:  Emily M Garland; Tericka S Cesar; Suzanna Lonce; Marcus C Ferguson; David Robertson
Journal:  Am J Clin Nutr       Date:  2013-04-03       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.